[Chronic intermittent peritoneal dialysis: a 12-year experience].
Since 1981, we have treated 46 adults aged 56 +/- 21 years, of whom 17 were diabetic, with intermittent peritoneal dialysis. Their mean time on dialysis has been 21 months with an accumulated experience of 493 months/patient. The program included 2 dialyses per week, 25 exchanges of 21 per session and 30 min of dwell time. Arterial pressure control has been satisfactory. Diabetic patients had lower levels of serum calcium, alkaline phosphatases and m-PTH. The incidence of peritonitis has been 1 episode/14 months/patient and the causative agent has been Staphylococcus aureus in 47% of episodes. Mean catheter duration has been 15 months and 1 episode/34 months/patient of exit site infection has been recorded and Staphylococcus aureus has been the causative agent in 83% of episodes. The risk of acquiring the first peritonitis was 12% at 3 months, 23% at 6 months and higher for non diabetic patients. Actuarial survival of treated patients at 12 and 24 months was 89 and 67% respectively. No differences in survival were recorded between diabetic and non diabetic patients. Fifty two percent of patients that dropped out continued on hemodialysis, 23% died, 11% abandoned treatment, 8% continued on chronic ambulatory peritoneal dialysis and 6% received a kidney allograft. We conclude that intermittent peritoneal dialysis is a good alternative treatment of chronic renal failure, even in diabetic patients.
García
R
R
Departamento de Nefrología, Hospital Almirante Nef, Facultad de Medicina, Universidad de Valparaíso, Chile.
Gómez
M
M
Olea
C
C
Cuadros
K
K
D000328:Adult; D000368:Aged; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000379:methods* / Q000401:mortality; D011379:Prognosis; D012189:Retrospective Studies
Peritoneo diálisis crónica intermitente: 12 años de experiencia.